The 9th International Congress on Drug Therapy in HIV Infection, Glasgow, November 2008
1 Predicting the short term risk of diabetes in HIV infected patients in the D:A:D cohort: The D:A:D study group. K Petoumenos, E Fontas, SW Worm, R Weber, S De Wit, M Bruyand, CA Sabin, P Reiss, W El-Sadr, A D´Arminio-Monforte, N Friis-Møller, JD Lundgren, M Law on behalf of the D:A:D study group.
Poster 152 KB
XVII International AIDS Conference, Mexico City, August 2008
1 Use of nucleos(t)ide reverse transcriptase inhibitors (NRTIs) and risk of myocardial infarction in HIV-infected patients enrolled in the SMART study. JD Lundgren and the SMART/INSIGHT and D:A:D Study Groups.
Slides 127 KB
15th Conference on Retroviruses and Opportunistic Infections, Boston, February 2008
1 Hepatitis Virus Co-infections and Risk of Diabetes Mellitus (DM) and Myocardial Infarction (MI) in HIV-infected Persons: The D:A:D Study. R Weber, C Sabin, P Reiss, S De Wit, S Worm, M Law, F Dabis, A d'Arminio Monforte, E Fontas, J Lundgren
Poster No. 1082 82 KB
2 Do Thymidine Analogues, Abacavir, Didanosine and Lamivudine Contribute to the Risk of Myocardial Infarction (MI)?
Recent Use of Abacavir and Didanosine, but not of Thymidine Analogues, Is Associated with Risk of Myocardial Infarction. Writing group: CA Sabin, SW Worm, R Weber, P Reiss, W El-Sadr, R Thiebaut, S De Wit, M Law, A D’Arminio Monforte, N Friis-Møller, O Kirk, C Pradier, S Collins, I Weller, AN Phillips, JD Lundgren on behalf of the D:A:D study group
Poster No. 957c 121 KB